ZelosDx is a Tucson-based company that specializes in developing blood testing products to aid researchers in making significant breakthroughs in brain health and disease. Their innovative solution addresses the challenges faced in the field of neurologic disease and brain trauma, offering low-cost blood testing products that can be used as tools for research, drug development, and early diagnosis.
By leveraging the discovery that phagocytic cells recruited to the brain can re-enter the bloodstream, ZelosDx has identified a novel source of brain-derived biomarkers in peripheral blood monocytes. This breakthrough technology allows for the detection of recent brain damage and active neurodegeneration, providing valuable insights into pathological changes in the brain. With their unique approach, ZelosDx aims to revolutionize the field and contribute to the advancement of effective treatments and improved patient outcomes.
Generated from the website